Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Early Completion of Medical Orders for Life-Sustaining Treatment (MOLST) and Hospice Enrollment Are Associated with Improved End of Life (EOL) Quality Metrics in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Marissa Locastro, BS, Kah Poh Loh, MBBCHBAO, Andrea M. Baran, MS, Jane L. Liesveld, MD, Michael W. Becker, MD, Kristen Marie O'Dwyer, MD, Eric Huselton, MD, Omar S. Aljitawi, MD, Megan Baumgart, MD, Eric Snyder, Benzi Kluger, MD, Jason H. Mendler, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-139475

Published: 2020

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)

Jodi J Lipof, MD, Dharmini Manogna, MD, Andrea M. Baran, MS, Bassil Said, MD, Michael W. Becker, MD, Jason H. Mendler, MD PhD, Omar S. Aljitawi, MD, Kristen Marie O'Dwyer, MD, Eric Huselton, MD, Richard Burack, MD PhD, Margaret Blaney, Taylor Douglas, Jane L. Liesveld, MD, Kah Poh Loh, MBBCHBAO

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136739

Published: 2020

Journal Articles

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition

Tamara K Moyo, MD PhD, Justin M. Watts, MD, Barry S. Skikne, MD, Jason H. Mendler, MD PhD, Virginia M. Klimek, MD, Sheau-Chiann Chen, PhD, Run Fan, PhD MS, Ingrid A Anderson, PhD, Andrew Sochacki, MD, Stephen A. Strickland, MD, Michael T Byrne, DO, Terrence J Bradley, MD, Gregory D Ayers, MS, Sanjay R Mohan, MD MSCI, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 4236.

https://doi.org/10.1182/blood-2019-130003

Published: 2019

Journal Articles

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Kah Poh Loh, MBBCHBAO, Sindhuja Kadambi, MD, Supriya G. Mohile, MD MS, Jason H. Mendler, MD PhD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Colin M. McHugh, MD, Marsha Wittink, MD MBE, Wendy Stock, MD, Navneet S. Majhail, MD MS, Tanya Wildes, MD, Paul Duberstein, PhD, Heidi D. Klepin, MD MS

Blood (2018) 132 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2018-99-114178

Published: 2018

Journal Articles

Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus on Geriatric Population

Kah Poh Loh, MBBCHBAO, Jian Liang Tan, Colin M. McHugh, MD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Jason H. Mendler, MD PhD, Omar S. Aljitawi, MD, Heidi D. Klepin, MD MS, Wendy Stock, MD, Tanya Wildes, MD, Andrew S Artz, MD, Areej El-Jawahri, MD, Navneet S. Majhail, MD MS

Blood (2018) 132 (Supplement 1): 2245.

https://doi.org/10.1182/blood-2018-99-112320

Published: 2018

Journal Articles

Dwjm-Adherence Induces Chemotherapy Resistance in Primary Acute Myeloid Leukemia By Altering Leukemia Cell Metabolism

Brea Lipe, MD, Thomas Conley, Hani Awad, PhD, Jason H. Mendler, MD PhD, Jason R Myers, MS, John M Ashton, PhD, Michael W. Becker, MD, Omar S. Aljitawi, MD

Blood (2018) 132 (Supplement 1): 3953.

https://doi.org/10.1182/blood-2018-99-117476

Published: 2018

Journal Articles

Suppression of mTOR Signaling Attenuates Apoptotic Effects Induced By the NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Acute Myeloid Leukemia Cells

Naxin Guo, PhD, Mary Nemer, Subanky Sivagnanalingam, Mitra Azadniv, PhD, Jason H. Mendler, MD PhD, Michael W. Becker, MD, Jane L. Liesveld, MD

Blood (2017) 130 (Supplement 1): 3820.

https://doi.org/10.1182/blood.V130.Suppl_1.3820.3820

Published: 2017

Journal Articles

ABO Identical and Washed Transfusions Are Candidate Strategies to Reduce Early Mortality in Acute Promyelocytic Leukemia (APL)

Majed A. Refaai, MD, Kelly F Henrichs, BS, MT(ASCP), Joanna M. Heal, MBBS, MRCP, Amy E Schmidt, MD PhD, Jason H. Mendler, MD PhD, Scott A. Kirkley, MD, Christopher Aquina, MD, Debra Masel, BS, MT(ASCP) SBB, Jane Liesveld, MD, Neil Blumberg, MD

Blood (2016) 128 (22): 4011.

https://doi.org/10.1182/blood.V128.22.4011.4011

Published: 2016

Journal Articles

Platelet Refractoriness Due to Anti-CD-36(NAK a ) Ameliorated By Platelet Washing

Tanmay Sahai, MD, Debra Masel, BS, MT(ASCP) SBB, Kelly F Henrichs, BS, MT(ASCP), Amy E Schmidt, MD PhD, Majed A. Refaai, MD, Scott A. Kirkley, MD, Jason H. Mendler, MD PhD, Neil Blumberg, MD

Blood (2016) 128 (22): 3857.

https://doi.org/10.1182/blood.V128.22.3857.3857

Published: 2016

Journal Articles

A Role for IL1RAP in Acute Myelogenous Leukemia Stem Cells Following Treatment and Progression

Tzu-Chieh Ho, PhD, Craig T Jordan, PhD, Mark W. LaMere, BA, John M. Ashton, PhD, Kristen O'Dwyer, MD, Jason H. Mendler, MD PhD, Jane L. Liesveld, MD, Eunice S. Wang, MD, Monica L. Guzman, PhD, Laura M. Calvi, MD, Michael W. Becker, MD

Blood (2015) 126 (23): 4266.

https://doi.org/10.1182/blood.V126.23.4266.4266

Published: 2015

Journal Articles

Distinct Properties of Leukemia Stem Cells in Primary Refractory Acute Myeloid Leukemia

Jason H. Mendler, MD PhD, Marlene Balys, Umayal Sivagnanalingam, Allison Eberhardt, Korinne Thorne, Tzu-Chieh Ho, PhD, Mark W. LaMere, BA, Samuel Moore, Helene McMurray, PhD, Jason R. Myers, John M. Ashton, PhD, Kristen O'Dwyer, MD, Jane L. Liesveld, MD, Laura M. Calvi, MD, Michael W. Becker, MD

Blood (2015) 126 (23): 685.

https://doi.org/10.1182/blood.V126.23.685.685

Published: 2015

Journal Articles

A Novel Xenograft Model of Cytogenetically Normal Acute Myeloid Leukemia Harboring RUNX1 and ASXL1 Mutations Demonstrates Residual Disease after Anthracycline/Cytarabine-Based Chemotherapy

Umayal Sivagnanalingam, BS, Marlene Balys, Allison Eberhardt, Nancy Wang, PhD, John M. Ashton, PhD, Jason H. Mendler, MD PhD

Blood (2014) 124 (21): 9.

https://doi.org/10.1182/blood.V124.21.9.9

Published: 2014

Journal Articles

Clinical and Biologic Effects Of The Angiopoietin 1/2 Neutralizing Peptibody, Trebananib (AMG 386), In Acute Myeloid Leukemia Patients

Eunice S. Wang, MD, Gerald Fetterly, PhD, William Brady, Wei Tan, Jessica Greene, Allison Gaudy, Carlos E Vigil, MD, Jason H. Mendler, MD, PhD, Michael W. Becker, MD, Kristen O'Dwyer, MD, Jane L. Liesveld, MD, Meir Wetzler, MD

Blood (2013) 122 (21): 2701.

https://doi.org/10.1182/blood.V122.21.2701.2701

Published: 2013

Journal Articles

Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML)

Jihane C Khalife, MS, Hanna S Radomska, PhD, Jennifer Saultz, MD, Ramasamy Santhanam, PhD, Xiaomeng Huang, Hongyan Wang, PhD, John P. Curfman, Yue-Zhong Wu, MS, Pia Hoellerbauer, Houda Alachkar, PharmD, PhD, Adrienne M Dorrance, Ph.D, Michael A. Caligiuri, MD, Ramiro Garzon, MD, Jason H. Mendler, MD, PhD, Guido Marcucci, MD

Blood (2013) 122 (21): 3804.

https://doi.org/10.1182/blood.V122.21.3804.3804

Published: 2013

Journal Articles

Evolution Of Acute Myelogenous Leukemia Stem Cell Properties Following Treatment and Progression

TzuChieh Ho, BS, Mark W LaMere, BS, Kristen O'Dwyer, MD, Jason H. Mendler, MD, PhD, Jane L. Liesveld, MD, Meir Wetzler, MD, Eunice S. Wang, MD, Monica L. Guzman, PhD, Craig T. Jordan, PhD, Michael W. Becker, MD

Blood (2013) 122 (21): 883.

https://doi.org/10.1182/blood.V122.21.883.883

Published: 2013

Journal Articles

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Blood (2013) 122 (21): 2540.

https://doi.org/10.1182/blood.V122.21.2540.2540

Published: 2013

Journal Articles

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)

Susan Whitman, PhD, Jessica Kohlschmidt, PhD, Kati Maharry, MAS, Deedra Nicolet, MS, Sebastian Schwind, MD, Heiko Becker, MD, Klaus H. Metzeler, MD, Krzysztof Mrózek, MD, PhD, Jason H. Mendler, MD, PhD, Ann-Kathrin Eisfeld, MD, Stefano Volinia, PhD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Jonathan E. Kolitz, MD, Richard M. Stone, MD, Il-Kyoo Park, Michael A. Caligiuri, M.D., Guido Marcucci, MD, Clara D. Bloomfield, MD

Blood (2012) 120 (21): 1293.

https://doi.org/10.1182/blood.V120.21.1293.1293

Published: 2012

Journal Articles

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

Blood (2012) 120 (21): 773.

https://doi.org/10.1182/blood.V120.21.773.773

Published: 2012

Journal Articles

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts)

Blood (2012) 120 (21): 1387.

https://doi.org/10.1182/blood.V120.21.1387.1387

Published: 2012

Journal Articles

Poor Outcome of RUNX1 -Mutated ( RUNX1 -mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,

Blood (2011) 118 (21): 3454.

https://doi.org/10.1182/blood.V118.21.3454.3454

Published: 2011

NARROW

Early Completion of Medical Orders for Life-Sustaining Treatment (MOLST) and Hospice Enrollment Are Associated with Improved End of Life (EOL) Quality Metrics in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus on Geriatric Population

Dwjm-Adherence Induces Chemotherapy Resistance in Primary Acute Myeloid Leukemia By Altering Leukemia Cell Metabolism

Suppression of mTOR Signaling Attenuates Apoptotic Effects Induced By the NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Acute Myeloid Leukemia Cells

ABO Identical and Washed Transfusions Are Candidate Strategies to Reduce Early Mortality in Acute Promyelocytic Leukemia (APL)

Platelet Refractoriness Due to Anti-CD-36(NAK a ) Ameliorated By Platelet Washing

A Role for IL1RAP in Acute Myelogenous Leukemia Stem Cells Following Treatment and Progression

Distinct Properties of Leukemia Stem Cells in Primary Refractory Acute Myeloid Leukemia

A Novel Xenograft Model of Cytogenetically Normal Acute Myeloid Leukemia Harboring RUNX1 and ASXL1 Mutations Demonstrates Residual Disease after Anthracycline/Cytarabine-Based Chemotherapy

Clinical and Biologic Effects Of The Angiopoietin 1/2 Neutralizing Peptibody, Trebananib (AMG 386), In Acute Myeloid Leukemia Patients

Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML)

Evolution Of Acute Myelogenous Leukemia Stem Cell Properties Following Treatment and Progression

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts)

Poor Outcome of RUNX1 -Mutated ( RUNX1 -mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only